Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Invested Capital (2016 - 2025)

Ptc Therapeutics (PTCT) has 10 years of Return on Invested Capital data on record, last reported at 1.09% in Q1 2025.

  • For Q1 2025, Return on Invested Capital fell 149.0% year-over-year to 1.09%; the TTM value through Mar 2025 reached 1.09%, down 149.0%, while the annual FY2025 figure was 0.23%, 55.0% down from the prior year.
  • Return on Invested Capital reached 1.09% in Q1 2025 per PTCT's latest filing, down from 0.29% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 77.82% in Q1 2022 and bottomed at 3.43% in Q4 2021.
  • Average Return on Invested Capital over 5 years is 4.66%, with a median of 0.39% recorded in 2024.
  • Peak YoY movement for Return on Invested Capital: surged 7893bps in 2022, then crashed -7637bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 3.43% in 2021, then surged by 131bps to 1.05% in 2022, then crashed by -48bps to 0.55% in 2023, then tumbled by -48bps to 0.29% in 2024, then plummeted by -482bps to 1.09% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 1.09% in Q1 2025, 0.29% in Q4 2024, and 0.14% in Q3 2024.